Navigation Links
Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture
Date:11/23/2009

BIRMINGHAM, Ala. and NOIDA, India, Nov. 23 /PRNewswire-USNewswire/ -- Jubilant Organosys, the University of Alabama at Birmingham (UAB), and Southern Research Institute today announced a joint venture that will focus on leveraging their collective innovation and enabling technologies in the areas of Oncology, Metabolic Disease and Infectious Diseases. It is a unique U.S.-India arbitraged and leveraged partnership that will accelerate the development of affordable therapies for patients worldwide. A Memorandum of Understanding was signed today in Washington, DC. Key components of the agreement include:

  • Selecting the most promising biological targets discovered by biomedical researchers at UAB, Southern Research and Jubilant;
  • Developing new drugs around these targets through work performed at UAB and Southern Research, and Jubilant in India;
  • Using early research data to secure federal funding to create new research jobs;
  • Developing drugs through Preclinical and or Phase 2 clinical trials to maximize value to potential licensees, and securing partnerships with the pharmaceutical industry; and,
  • Licensing drugs to the pharmaceutical industry with revenues distributed to investment participants in milestone payments and royalty streams.

Commenting on the development Shyam S. Bhartia, Chairman and Managing Director, and Hari S Bhartia, Co-chairman and Managing Director, Jubilant Organosys, said, "This novel academic and industrial collaboration demonstrates our commitment to partner with globally renowned academia in order to identify and deliver affordable innovation and healthcare solutions to the patients worldwide. We are happy to join hands with UAB and Southern Research Institute, known for its strengths in the areas of oncology, metabolic disease and infectious diseases. The collective innovation capabilities of this partnership further augments our mission to be the most innovative Drug Discovery and Development group in India, accelerating global drug development."

Jubilant, through subsidiaries like Biosys, Chemsys and Clinsys, has developed strong partnerships in the area of research with leading academic institutions to support them in translation of early stage science and with innovative pharmaceutical companies to accelerate their drug discovery programs.

UAB receives more than $400 million annually in research grants and contracts and ranks in the top 25 nationally in National Institutes of Health (NIH) funding; it is a rich source of biological targets for drug development.

"UAB has tremendous strength in research that identifies the targets -- usually proteins -- that contribute to the disease process, whether it is cancer or diabetes, which develop when our bodies malfunction, or a virus or bacterial infection that invades from outside," said Richard B. Marchase, UAB Vice President for Research and Economic Development. "Southern Research and Jubilant have the expertise, scientific workforce, and the equipment to take those findings and move them rapidly through the drug discovery and testing phases that lead to new commercially viable products."

Southern Research has earned worldwide acclaim for its success translating basic research into drugs that can be used to treat human illness, having discovered and helped move seven FDA-approved cancer drugs to market, with five more drugs in late-stage preclinical and early clinical studies.

"Southern Research has proven that it can help move promising drug candidates into the marketplace -- our clients' drugs as well as own discoveries," said John A. "Jack" Secrist III, Ph.D., President and CEO of Southern Research Institute. "What we are creating through this joint venture is a powerful new drug discovery engine that will leverage research strengths in Alabama, as well as our collective industry strengths, to drive products to market."

About Jubilant Organosys

Jubilant Organosys Limited, an integrated pharmaceutical industry player, is the largest custom research and manufacturing services (CRAMS) Company out of India. The company has a presence across the pharmaceutical value chain for providing products and services such as proprietary products, exclusive synthesis, active pharmaceutical ingredients, contract manufacturing of sterile injectables & non-steriles products, radiopharmaceuticals, generic dosage forms, drug discovery services, medicinal chemistry services, clinical research services, and Healthcare. The Company also manufactures Industrial and Performance products. For more information: www.jubl.com.

About the UAB Research Foundation (UABRF)

The UAB Research Foundation plays a significant role in commercializing research, to the benefit of local and state economic development. The foundation's commercialization of faculty discoveries has since 1986 created more than $35 million in royalty and license fees, 1,800 invention disclosures, more than 450 patents, and more than 600 license, option and research agreements. The UABRF has assisted in the formation of 39 spin-off companies.

About Southern Research

Southern Research Institute is a nonprofit 501(c)3 scientific research organization that conducts preclinical drug discovery and development, and advanced engineering research in materials, systems development, environment and energy. Our more than 550 scientific and engineering team members support clients and partners in the pharmaceutical, biotechnology, defense, aerospace, environmental and energy industries. Southern Research is headquartered in Birmingham, Ala., with facilities in Wilsonville, Ala., Anniston, Ala., Frederick, Md., and Durham, NC and offices in New Orleans, La., Washington, DC and Kiev, Ukraine. For more information about Southern Research and its capabilities and accomplishments, visit www.SouthernResearch.org.

For Media:

Jubilant Organosys

Seema Ahuja
seema_ahuja@jubl.com

For Investors:
Jubilant Organosys
Deepak Malik

deepak_malik@jubl.com

Media Contact:
UAB

Dale Turnbough

dalet@uab.edu

Media Contact:
Southern Research

Rhonda Jung

jung@southernresearch.org

SOURCE Southern Research Institute


'/>"/>
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Jubilant Enters Research Collaboration With AstraZeneca
2. Diplomat Specialty Pharmacy Continues to Expand - Opens Location in Southern California
3. Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession
4. Trana Discovery and Southern Research Institute Find Bioactive HIV Antiviral Compounds
5. Southern Research to Play Key Role in the Federal Governments Search for New Cancer Therapies
6. Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network
7. Trana Discovery and Southern Research Institute Announce the First RNA-RNA High Throughput Drug Screening Assay Platform for HIV Antivirals
8. Reprocessed Catheters: A Growing Force In the US Electrophysiology Diagnostic Catheter Market, According to Millennium Research Group
9. Caliper Life Sciences Partners with Prestwick Chemical to Offer Customized Chemistry and Biology Programs for Drug Discovery Research
10. Malaria Experts Call on Federal Government to Increase Support for Research and Development
11. WebMD to Present at the 2009 Citi Investment Research Small and Mid Cap Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... , April 28, 2016 TapImmune,Inc. ... of innovative peptide and gene-based immunotherapeutics and vaccines for the ... be presenting at the 3rd Annual Growth Capital Expo ... th , 2016 at Caesars Palace in Las Vegas, Nevada.  ... on Wednesday, May 4 th by Dr. John ...
(Date:4/27/2016)...   , Total ... Consumable Sales  Clinical sales grow 16% year-over-year  ... MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary confocal ... first quarter ended March 31, 2016 and provided an ... commercial strategy. First Quarter 2016 Revenue Results ...
(Date:4/27/2016)... SHAWNEE, Kan. , April 27, 2016 /PRNewswire/ ... Martabano , a senior from the University of ... winner of the Bayer Excellence in Communication Award ... veterinary schools, which were awarded a total of ... Over the last four years, Bayer has provided ...
Breaking Medicine Technology:
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... On Tuesday, ... hospitals across the Southeast, celebrated the signature of Gov. Nathan Deal on SB 258, ... Geoff Duncan (R - Cumming), offers a 70% tax credit to individuals and corporations ...
(Date:4/29/2016)... ... April 29, 2016 , ... The White House ... their loans, more information about their loan terms and accounts, and more protections ... debt, including federal and private loans, has reached $1.3 trillion, with 43 million ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... that infants born with severe congenital diaphragmatic hernia have better survival rates if ... congenital diaphragmatic hernia (CDH)—a condition where the diaphragm fails to form completely, letting ...
(Date:4/29/2016)... ... April 29, 2016 , ... Mobility Designed is ... pressure on the armpits, the M+D Crutch evenly distributes body weight from the elbow ... and hands when using the crutches than with other crutches. , Co-founders Max and ...
(Date:4/29/2016)... Tarzana, CA (PRWEB) , ... April 29, 2016 , ... Melanoma is the deadliest type ... is to blame for the majority of skin cancer deaths. More than 10,000 people are ... average age at diagnosis is 62, it is the one of the most commonly diagnosed ...
Breaking Medicine News(10 mins):